ReSync Bio

ReSync Bio offers an AI-enabled drug discovery platform that streamlines preclinical operations for biotech companies. Their solution integrates AI models, virtual screening workflows, and experimental requests, reducing operational bottlenecks and accelerating drug discovery timelines. Key benefits include automating manual processes, centralizing disparate data and software, and enhancing data security. ReSync aims to enable AI adoption by providing a turnkey data engineering solution, allowing biotech firms to train and host ML models efficiently. The platform supports various use cases, including preclinical science, academic research, finance (R&D payment reconciliation), and biotech management, ultimately helping companies preserve runway and make faster decisions.